ArticleCell reports. Medicine2024

Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.

Patrick Yu-Wai-Man et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.